Awards & Recognition
We are proud that Cephalon - our company, founder, management and employees - are regularly recognized for their leadership and commitment to industry innovation, research excellence, superior customer service, and strong community partnerships. View highlights from this and past years or download a more complete listing of our awards and recognition.
Frank Baldino named 2009 CEO of the Year by Chester County Chamber of Business & Industry
The Chester County Chamber of Business & Industry recognized Frank Baldino, Jr., PhD for his contributions and service to the Chester County and Greater Philadelphia communities, and for his leadership in the pharmaceutical industry and to the company he founded 22 years ago. He was named 2009 CEO of the Year by the organization.
Cephalon Ranks #6 in Pharmaceutical Executive’s 2009
Industry Audit
In an annual industry performance audit of publicly-traded pharmaceutical, biotechnology and generics companies, Cephalon ranked 6 of 27 based on an analysis of key 2007-2008 performance metrics, including change in revenue and enterprise value, enterprise value to sales, and profit to assets.
Cephalon Named One of America's Best Adoption-Friendly Workplaces
For the second consecutive year, Cephalon was named one of America’s best adoption-friendly workplaces by the Dave Thomas Foundation for Adoption. The list, determined by an analysis of adoption benefits available to employees, ranked Cephalon #2 among pharmaceutical companies and #36 of the top 100 companies.
Cephalon included in Fortune 1000
Cephalon was named to the 2009 Fortune list of America’s 1000 largest companies for the third consecutive year, rising in rank from 952 to 903 in the complete list of American’s largest companies. In the list of the largest pharmaceutical companies, Cephalon ranked 20
Forbes names Cephalon to Platinum 400 List of the Best Big Companies in America
For the second time, Cephalon was named to the Forbes listing of the Best Big Companies in America, based on factors that included sales and earnings growth, debt to total capital ratio, earnings outlook and stock market returns. Cephalon was one of just 14 companies in the Drugs and Biotechnology sector included in the 2008 listing.
Cephalon Ranks as One of the Country's Best
Cephalon was recognized for the second consecutive year as one of the country’s best adoption-friendly workplaces by the Dave Thomas Foundation for Adoption, based on financial reimbursement and paid leave available to employees.